{"code":"F15.21","type":"code","title":"Other stimulant dependence, in remission","codeAlso":[],"includes":["amphetamine-related disorders","caffeine"],"modern_v":"official26","codeFirst":[],"excludes1":["other stimulant abuse (F15.1-)","other stimulant use, unspecified (F15.9-)"],"excludes2":["cocaine-related disorders (F14.-)"],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":true,"billableFy2027":true},"inclusionTerms":["Amphetamine type substance use disorder, moderate, in early remission","Amphetamine type substance use disorder, moderate, in sustained remission","Amphetamine type substance use disorder, severe, in early remission","Amphetamine type substance use disorder, severe, in sustained remission","Other or unspecified stimulant use disorder, moderate, in early remission","Other or unspecified stimulant use disorder, moderate, in sustained remission","Other or unspecified stimulant use disorder, severe, in early remission","Other or unspecified stimulant use disorder, severe, in sustained remission"],"useAdditionalCode":[],"clinicalDefinition":"Other stimulant dependence, in remission is a billable ICD-10-CM diagnosis code (F15.21). Includes: amphetamine-related disorders; caffeine.","officialDefinition":"Other stimulant dependence, in remission is a billable ICD-10-CM diagnosis code (F15.21). Includes: amphetamine-related disorders; caffeine. Inclusion terms: Amphetamine type substance use disorder, moderate, in early remission; Amphetamine type substance use disorder, moderate, in sustained remission; Amphetamine type substance use disorder, severe, in early remission; Amphetamine type substance use disorder, severe, in sustained remission; Other or unspecified stimulant use disorder, moderate, in early remission; Other or unspecified stimulant use disorder, moderate, in sustained remission; Other or unspecified stimulant use disorder, severe, in early remission; Other or unspecified stimulant use disorder, severe, in sustained remission. Excludes1 (not coded here): other stimulant abuse (F15.1-); other stimulant use, unspecified (F15.9-). Excludes2 (not included here): cocaine-related disorders (F14.-).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":"","noteProvenance":{"cocaine-related disorders (F14.-)":"F15","amphetamine-related disorders":"F15","caffeine":"F15","other stimulant abuse (F15.1-)":"F15.2","other stimulant use, unspecified (F15.9-)":"F15.2"},"hcc":{"mapped":true,"model":"CMS-HCC V28","paymentYear":"2026","categories":[{"hcc":"137","label":"Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications","family":"SUD","suppresses":[{"hcc":"138","label":"Drug Use Disorder, Mild, Uncomplicated, Except Cannabis"},{"hcc":"139","label":"Alcohol Use Disorder, Moderate/Severe, or Alcohol Use with Specified Non-Psychotic Complications"}]}],"otherModels":[{"model":"CMS-HCC V22","hcc":"55"}]}}